tiprankstipranks
Advertisement
Advertisement

Braskem Posts Weak 4Q25 EBITDA as Brazil Approves New Chemical Industry Incentives

Story Highlights
  • Braskem’s 4Q25 results showed pressured spreads, lower plant utilization and recurring EBITDA of US$109 million amid a prolonged petrochemical downcycle.
  • Brazil enacted new PRESIQ and enhanced REIQ incentives in late 2025 and March 2026, measures Braskem says are vital for the sector’s long-term competitiveness.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Braskem Posts Weak 4Q25 EBITDA as Brazil Approves New Chemical Industry Incentives

Meet Samuel – Your Personal Investing Prophet

Braskem SA ( (BAK) ) has issued an announcement.

Braskem reported that conditions in the global petrochemical market remained weak in the fourth quarter of 2025, with geopolitical tensions, trade frictions and seasonal effects further compressing international chemical and petrochemical spreads. The company recorded consolidated recurring EBITDA of US$109 million for 4Q25, pressured by lower utilization rates in Brazil/South America and in the United States and Europe, and ended the period with gross debt of US$9.4 billion, cash of US$2.1 billion and corporate leverage of 14.74x.

Operationally, the Brazil/South America segment saw a 6‑percentage‑point drop in average utilization due mainly to a scheduled shutdown at the Bahia complex and seasonal demand, cutting recurring EBITDA for the region to US$143 million, down 30% versus 3Q25. Utilization in the United States and Europe fell 8 percentage points amid planned outages and inventory optimization, leading to a negative recurring EBITDA of US$32 million, while Mexico rebounded from prior maintenance with a 38‑point utilization increase and recurring EBITDA of US$11 million.

For stakeholders, the quarter also brought important policy developments supporting Brazil’s chemical chain, including the December 2025 enactment of Law No. 15,294/25 creating the Special Sustainability Program for the Chemical Industry (PRESIQ) from 2027 to 2031 and the March 2026 approval of Complementary Law No. 228, which significantly raises the benefit under the Special Regime for the Chemical Industry (REIQ). These measures are framed by Braskem as essential to the long‑term competitiveness and continuity of the Brazilian chemical and petrochemical sector and may help offset the impact of the current industry downcycle on future operations.

The most recent analyst rating on (BAK) stock is a Sell with a $2.80 price target. To see the full list of analyst forecasts on Braskem SA stock, see the BAK Stock Forecast page.

Spark’s Take on BAK Stock

According to Spark, TipRanks’ AI Analyst, BAK is a Neutral.

Braskem SA’s overall stock score reflects significant financial challenges, with high leverage and declining profitability being the most critical factors. While there are some positive aspects, such as improved EBITDA and liquidity, these are overshadowed by ongoing industry pressures and valuation concerns. Technical analysis provides a neutral outlook, with mixed signals on momentum.

To see Spark’s full report on BAK stock, click here.

More about Braskem SA

Braskem S.A. is a Brazilian petrochemical company and the largest resin producer in the Americas, with shares listed in São Paulo, New York and on Latibex. The group is also a global leader in biopolymers, supplying resins and chemicals to industrial clients across Brazil/South America, the United States, Europe and Mexico, with a strong focus on large petrochemical complexes.

Average Trading Volume: 2,261,491

Technical Sentiment Signal: Hold

Current Market Cap: $1.44B

See more insights into BAK stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1